Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVERT-2: Abatacept + Methotrexate in Early RA
NCT02504268Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Sep 2015
- Primary completion
- Jan 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 31
01
Overview
A Phase 3 trial of abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Sep 2015; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02504268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02504268.